by Keck School of Medicine of USC edited by Sadie Harley, reviewed by Andrew Zinin Editors’ notes Credit: Unsplash/CC0 Public Domain New prostate cancer research from an international team led by the Center for Genetic Epidemiology at the Keck School of Medicine of USC has yielded discoveries that could improve screening and treatment for patients of African ancestry. […]
by Anna Megdell, University of Michigan edited by Stephanie Baum, reviewed by Robert Egan Editors’ notes p300/CBP-catalyzed H2BNTac is significantly elevated in prostate cancer lesions compared with normal prostate epithelia. a, Representative multiplex immunofluorescence images of H2BK5ac/KRT8 (green and gray) and H2BK20ac/KRT8 (cyan and gray) staining in patient-matched adjacent benign and tumor tissues. Magnification, ×200. b. H2BK5ac and H2BK20ac IF
Researchers find a new targeted approach to shut down prostate cancer growth Read More »
Researchers identify previously unknown mechanism in tumour growth Peer-Reviewed Publication Medical University of Vienna An international research team led by the Medical University of Vienna has demonstrated for the first time that thyroid hormone plays a key role in the development and progression of prostate cancer. By blocking a specific thyroid hormone receptor, cancer growth
New approach to prostate cancer treatment Read More »
by University College London edited by Sadie Harley, reviewed by Robert Egan Editors’ notes Credit: Unsplash/CC0 Public Domain A new drug combination could significantly delay the progression of a life-threatening form of prostate cancer in men with specific genetic mutations, finds a major international trial led by UCL researchers. The Phase III AMPLITUDE trial, published in Nature Medicine, tested
Novel drug combination offers hope for men with advanced prostate cancer Read More »
by University of Oslo edited by Lisa Lock, reviewed by Robert Egan Editors’ notes Schematic illustration of the Wnt–β-catenin signaling pathway with or without exon 3-mutated β-catenin. Credit: Nature Immunology (2025). DOI: 10.1038/s41590-025-02252-1 Researchers at the University of Oslo and Oslo University Hospital have developed a promising new immunotherapy targeting the CTNNB1 gene mutation associated with various aggressive cancers such
September 22nd, 2025Posted by Johns Hopkins University (Credit: Getty Images) Share this Article Facebook Twitter Reddit Email You are free to share this article under the Attribution 4.0 International license. Tags cancer prostate cancer urine University Johns Hopkins University Researchers have created a new urine-based test to ID prostate cancers. This new approach could significantly reduce the
New pee test could identify prostate cancer Read More »
by University of Washington School of Medicine edited by Andrew Zinin Credit: Unsplash/CC0 Public Domain Although Black men die of prostate cancer at twice the rate of the rest of U.S. males, this fact often is not known or considered during appointments with their primary-care clinicians to discuss a common screening test. The new qualitative study published this
Study finds primary-care doctors often overlook prostate cancer risk in Black men Read More »
by American Cancer Society edited by Sadie Harley, reviewed by Robert Egan Late-stage incidence rates continue to increase rapidly as mortality declines slow. Credit: American Cancer Society The American Cancer Society (ACS) has released Prostate Cancer Statistics, 2025, a report on current prostate cancer occurrence and outcomes in the United States. According to the study, prostate cancer
by Ohio State University Medical Center edited by Sadie Harley, reviewed by Andrew Zinin Edmund Folefac, M.D., genitourinary medical oncologist at The Ohio State University Comprehensive Cancer Center—Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, emphasizes the importance of regular prostate cancer screenings for men around age 50. Credit: The Ohio State University Comprehensive Cancer
by Elizabeth Chapin, University of Kentucky edited by Sadie Harley, reviewed by Andrew Zinin Graphical abstract. Credit: Journal of Clinical Investigation (2025). DOI: 10.1172/JCI185119 University of Kentucky Markey Cancer Center researchers have identified a cellular pathway that fuels the progression of aggressive, drug-resistant prostate cancer. The findings of the study, published in the Journal of Clinical Investigation, could lead to
Study identifies molecular pathway that drives advanced prostate cancer Read More »
Vitae, vulputate lorem id egestas neque egestas habitant sit ante nec.
✆ Phone (appointments): 714-639-4013
Email: care@imedmg.com
Address: 615 E Chapman Ave, Suite #300, Orange, CA 92866